Quantcast

Colorado will receive a share of a $95.5 million pharmaceutical settlement (access required)

by Rob Larimer

Published: June 9,2009

Time posted: 10:18 am

Tags: pharmaceutical

Share this story:
Colorado will receive more than $376,000 as part of a $95.5 million global settlement with Aventis Pharmaceuticals. The agreement resolves allegations that between 1995 and 2000, Aventis and its corporate predecessors knowingly misreported best prices for the steroid-based anti-inflammatory nasal sprays Azmacort, Nasacort and Nasacort AQ. Under the agreement, state Medicaid programs throughout the country received ...





  • Comments are closed.





    Connect with us: Daily Email Facebook Twitter LinkedIn

    Our Poll

    Are you more or less optimistic about the CSBJ now that it will be locally owned?

    View Results

    Loading ... Loading ...

    This poll is not a scientific sampling, but offers a quick view of what readers are thinking.

    Calendar

    On The Horizon: Read calendar items from the print edition of the Business Journal here.

    To submit your event to our community calendar, set up the event as an appointment in your email calendar and invite events.csbj@gmail.com as an attendee.



    • image
    • image
    • image
    Copyright © 2012  | Colorado Springs Business Journal  31 E. Platte Ave., Ste 300, Colorado Springs, CO 80903  (719) 634-5905